Miami, Florida, United States
Senior / executive leader with 10 years+ senior leadership experience, strong management, commercial and scientific background, and experience in varies therapeutic areas for therapeutic drugs and medical devices in private & public companies. Good understanding of US and European drug environment and high social skills for leading/collaborating with internal and external teams and negotiating with international companies and academic partners. Strong business background including full P&L responsibility and managing and tracking of budgets. Lead in several M&A deals including securing of $20M plus investment and $50M plus deal value. Over 20 years of international experience in US NASDAQ listed companies and private Start-Up companies including setting up companies / structures from the scratch and building international organizations and teams. International cultural experience with US, Japanese, Chinese and European companies. Proven competency in leading multicultural teams. Experienced commercial leader with strong track record of successful product launches in several therapeutic areas including medical devices. Experienced in early and clinical development as well as market access, marketing & sales strategies, and manufacturing. Led companies through different life cycles - involved in transformational projects like setting-up new companies, preparations for reverse merger / IPO, turn-around strategies, rapidly building teams and managing organizations cost-effectively to success. Leader with a passion for company growth, thinking in solutions rather than problems and working hands-on. Fluent in English and German with basic conversational knowledge in Spanish.
With patients at the forefront of everything we do, subrosa Health & Capital enables Rare Disease and Biotech originators to achieve accelerated access to patients, commercialization pathways, global markets, elite talent & capital – from early drug development to launch by a worldwide connected, intelligent, and trusted ecosystem. subrosa combines its proprietary global patient database & unique AI supported clinical programs for optimized and accelerated early patient identification. Our end-to-end medical, commercial & regulatory launch services combined with strategic market access decision optimizations, executive search, commercial partnering & holistic patient solutions under one roof reduce complexity & shorten timelines for our clients to achieve their commercial goals faster and leave no patient behind. BE ACCELERATED.
Leading the clinical and pre-clinical development of the Naya Therapeutics pipeline with several bi-functional Antibodies to treat cancer and Auto-Immune diseases.